{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:04:36Z","timestamp":1767110676861,"version":"3.48.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Congenital cytomegalovirus (cCMV) infection is a leading cause of sensorineural hearing loss in children. Recent evidence that high-dose valacyclovir reduces vertical transmission following primary maternal infection has renewed the urgency for screening. We investigated the utility of quantifying cell-free CMV DNA from noninvasive prenatal screening (NIPS) data to identify pregnancies at risk for primary CMV infection and cCMV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, we analyzed NIPS data from 22 333 unselected pregnancies at 12 weeks gestation. CMV-aligned reads were quantified from low-pass whole-genome sequencing data and validated against quantitative PCR (qPCR) for viral load, maternal serology for infection status and systematic newborn screening for cCMV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CMV read counts demonstrated good correlation with qPCR-measured viral loads (rs = 0.76; 95%CI: 0.68\u20130.81). Presence of \u22651 CMV read count (2.1% of pregnancies) was highly predictive of cCMV [likelihood ratio (LR) = 21.1; 95% confidence interval (CI): 14.9\u201330.1]. CMV read counts showed good diagnostic accuracy for primary infection [area under the receiver operator characteristic curve (AUROC) = 0.77; 95% CI: 0.72\u20130.82] and for cCMV (AUROC = 0.82; 95% CI: 0.76\u20130.86). A threshold of \u22654 read counts identified a subgroup with significantly elevated risk for primary infection (LR = 7.8; 95% CI: 4.3\u201314.2) and cCMV (LR = 6.0; 95% CI: 3.3\u201310.8), achieving positive predictive value for cCMV of 51.7%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Quantification of CMV DNA during NIPS is an accurate and sensitive method for CMV viral load. This approach effectively stratifies risk for both primary maternal infection and cCMV, enabling identification of pregnancies that may benefit from antiviral therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaf159","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:55:48Z","timestamp":1763038548000},"page":"173-182","source":"Crossref","is-referenced-by-count":0,"title":["Universal Screening of Cytomegalovirus Viral Load by Low-Pass Whole-Genome Sequencing in First-Trimester Pregnancy: Clinical Validation"],"prefix":"10.1093","volume":"72","author":[{"given":"Pauline H","family":"Herroelen","sequence":"first","affiliation":[{"name":"AZ Delta Medical Laboratories, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Swaerts","sequence":"additional","affiliation":[{"name":"AZ Delta Medical Laboratories, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Descheemaeker","sequence":"additional","affiliation":[{"name":"AZ Delta Medical Laboratories, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Claerhout","sequence":"additional","affiliation":[{"name":"AZ Delta, Department of Gynaecology and Obstetrics, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan","family":"Vanderstichele","sequence":"additional","affiliation":[{"name":"AZ Delta, Department of Gynaecology and Obstetrics, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Boone","sequence":"additional","affiliation":[{"name":"AZ Delta Medical Laboratories, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"De Cuyper","sequence":"additional","affiliation":[{"name":"AZ Delta Medical Laboratories, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Van Hoecke","sequence":"additional","affiliation":[{"name":"AZ Delta Medical Laboratories, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1208-6289","authenticated-orcid":false,"given":"Geert A","family":"Martens","sequence":"additional","affiliation":[{"name":"AZ Delta Medical Laboratories, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]},{"name":"Department of Biomolecular Medicine, Ghent University , Gent ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"De Smet","sequence":"additional","affiliation":[{"name":"AZ Delta Medical Laboratories, AZ Delta General Hospital , Roeselare ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2025123011001534000_hvaf159-B1","doi-asserted-by":"crossref","first-page":"100892","DOI":"10.1016\/j.lanepe.2024.100892","article-title":"Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)","volume":"40","author":"Leruez-Ville","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2025123011001534000_hvaf159-B2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","article-title":"Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences","volume":"223","author":"Chatzakis","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2025123011001534000_hvaf159-B3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/pd.6397","article-title":"Serological screening for cytomegalovirus during pregnancy: a systematic review of clinical practice guidelines and consensus statements","volume":"43","author":"Xie","year":"2023","journal-title":"Prenat Diagn"},{"key":"2025123011001534000_hvaf159-B4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"key":"2025123011001534000_hvaf159-B5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/uog.26136","article-title":"Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis","volume":"61","author":"D\u2019Antonio","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025123011001534000_hvaf159-B6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/pd.6116","article-title":"Clinically relevant DNA viruses in pregnancy","volume":"43","author":"Linthorst","year":"2023","journal-title":"Prenat Diagn"},{"key":"2025123011001534000_hvaf159-B7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2018.08.016","article-title":"Genomic analyses from non-invasive prenatal testing reveal genetic associations, patterns of viral infections, and Chinese population history","volume":"175","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"2025123011001534000_hvaf159-B8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/pd.6143","article-title":"The cell-free DNA virome of 108,349 Dutch pregnant women","volume":"43","author":"Linthorst","year":"2023","journal-title":"Prenat Diagn"},{"key":"2025123011001534000_hvaf159-B9","first-page":"228","article-title":"Distinct fragmentation patterns of circulating viral cell-free DNA in 83,552 non-invasive prenatal testing samples","volume":"2","author":"Linthorst","year":"2021","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"2025123011001534000_hvaf159-B10","doi-asserted-by":"crossref","first-page":"104983","DOI":"10.1016\/j.ebiom.2024.104983","article-title":"Early detection of active human CytomegaloVirus (hCMV) infection in pregnant women using data generated for noninvasive fetal aneuploidy testing","volume":"100","author":"Faas","year":"2024","journal-title":"EBioMedicine"},{"key":"2025123011001534000_hvaf159-B11","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1038\/s41598-018-22414-6","article-title":"Using massively parallel shotgun sequencing of maternal plasmatic cell-free DNA for cytomegalovirus DNA detection during pregnancy: a proof of concept study","volume":"8","author":"Chesnais","year":"2018","journal-title":"Sci Rep"},{"key":"2025123011001534000_hvaf159-B12","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1038\/s41598-020-60655-6","article-title":"High-resolution profiling of human cytomegalovirus cell-free DNA in human plasma highlights its exceptionally fragmented nature","volume":"10","author":"Peddu","year":"2020","journal-title":"Sci Rep"},{"key":"2025123011001534000_hvaf159-B13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/uog.29221","article-title":"Metagenomic analysis of NIPT raw data suggests high negative predictive value for congenital cytomegalovirus infection screening","volume":"65","author":"Bourgon","year":"2025","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025123011001534000_hvaf159-B14","author":"Swaerts"},{"key":"2025123011001534000_hvaf159-B15","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"2025123011001534000_hvaf159-B16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"2025123011001534000_hvaf159-B17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"key":"2025123011001534000_hvaf159-B18","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/JCM.01495-15","article-title":"Commutability of the first World Health Organization international standard for human cytomegalovirus","volume":"53","author":"Hayden","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2025123011001534000_hvaf159-B19","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/cid\/cit096","article-title":"Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients","volume":"56","author":"Razonable","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2025123011001534000_hvaf159-B20","doi-asserted-by":"crossref","first-page":"e29139","DOI":"10.1002\/jmv.29139","article-title":"Amplicon size and non-encapsidated DNA fragments define plasma cytomegalovirus DNA loads by automated nucleic acid testing platforms: a marker of viral cytopathology?","volume":"95","author":"Leuzinger","year":"2023","journal-title":"J Med Virol"},{"key":"2025123011001534000_hvaf159-B21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/cid\/cix344","article-title":"Public health impact of congenital toxoplasmosis and cytomegalovirus infection in Belgium, 2013: a systematic review and data synthesis","volume":"65","author":"Smit","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025123011001534000_hvaf159-B22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/JCM.02044-16","article-title":"Progress in quantitative viral load testing: variability and impact of the WHO quantitative international standards","volume":"55","author":"Hayden","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2025123011001534000_hvaf159-B23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/302205","article-title":"Rapid clearance of fetal DNA from maternal plasma","volume":"64","author":"Lo","year":"1999","journal-title":"Am J Hum Genet"},{"key":"2025123011001534000_hvaf159-B24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jcv.2014.10.002","article-title":"Cytomegalovirus DNAemia in pregnant women","volume":"61","author":"Revello","year":"2014","journal-title":"J Clin Virol"},{"key":"2025123011001534000_hvaf159-B25","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1086\/515277","article-title":"Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy","volume":"177","author":"Revello","year":"1998","journal-title":"J Infect Dis"},{"key":"2025123011001534000_hvaf159-B26","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/323425","article-title":"Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns","volume":"184","author":"Revello","year":"2001","journal-title":"J Infect Dis"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/1\/173\/66163335\/hvaf159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/1\/173\/66163335\/hvaf159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:00:31Z","timestamp":1767110431000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/72\/1\/173\/8407350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2025,12,30]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaf159","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,30]]}}}